CESAR AUGUSTO NUNEZ

TitleAssociate Professor
InstitutionMD Anderson
DepartmentPediatrics
Address1515 Holcombe Blvd
Houston TX 77030-4009
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. McCall D, Alqahtani S, Budak M, Sheikh I, Fan AE, Ramakrishnan R, Nunez C, Roth M, Garcia MB, Gibson A, Daver N, Garces S, Short NJ, Issa GC, Ravandi F, DiNardo CD, Montalban Bravo G, Garcia-Manero G, Cuglievan B, Kadia T. Cladribine-Based Therapy for Acute Myeloid Leukemia in Child, Adolescent, and Early Young Adult Patients: The MD Anderson Cancer Center Experience. Cancers (Basel). 2024 Nov 20; 16(22). PMID: 39594839; PMCID: PMC11592422.
      Citations:    
    2. Gibson A, Nunez C, Robusto L, Kammerer B, Garcia M, Roth M, Sheth R, Tewari P, Hittle A, Toepfer L, Torres R, Short NJ, Jabbour E, Jain N, Cuglievan B, McCall D. Combination low-intensity chemotherapy plus inotuzumab ozogamicin, blinatumomab and rituximab for pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia. Haematologica. 2024 Sep 01; 109(9):3042-3047. PMID: 38779719; PMCID: PMC11367183.
      Citations:    Fields:    Translation:Humans
    3. Cuglievan B, Kantarjian H, Rubnitz JE, Cooper TM, Zwaan CM, Pollard JA, DiNardo CD, Kadia TM, Guest E, Short NJ, McCall D, Daver N, Nunez C, Haddad FG, Garcia M, Bhalla KN, Maiti A, Catueno S, Fiskus W, Carter BZ, Gibson A, Roth M, Khazal S, Tewari P, Abbas HA, Bourgeois W, Andreeff M, Shukla NN, Truong DD, Connors J, Ludwig JA, Stutterheim J, Salzer E, Juul-Dam KL, Sasaki K, Mahadeo KM, Tasian SK, Borthakur G, Dickson S, Jain N, Jabbour E, Meshinchi S, Garcia-Manero G, Ravandi F, Stein EM, Kolb EA, Issa GC. Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international community. Leukemia. 2024 Oct; 38(10):2073-2084. PMID: 39179671; PMCID: PMC11436367.
      Citations:    Fields:    Translation:Humans
    4. Gibson A, Dickson S, McCall D, Garcia M, Connors J, He J, Roth M, Nunez C, Cuglievan B. Venetoclax for pediatric patients with newly diagnosed acute myeloid leukemia. Pediatr Blood Cancer. 2024 Nov; 71(11):e31286. PMID: 39152634.
      Citations:    Fields:    Translation:Humans
    5. Nash A, Weirda W, Albritton K, Cuglievan B, Garcia M, McCall D, Nunez C, Gibson A. Rare case of chronic lymphocytic leukemia in an adolescent treated with targeted therapy. Pediatr Blood Cancer. 2024 Sep; 71(9):e31101. PMID: 38872414.
      Citations:    Fields:    Translation:Humans
    6. Alqahtani S, Ramakrishnan R, E S, Wang SA, Nunez C, McCall D, Garcia MB, Roth ME, Cuglievan B, Gibson A. Venetoclax use in a patient with ataxia telangiectasia and early T-cell precursor acute lymphoblastic leukemia. Pediatr Blood Cancer. 2024 Aug; 71(8):e31123. PMID: 38837565.
      Citations:    Fields:    Translation:Humans
    7. Okeleji O, Gibson A, Nunez C, Garcia MB, Roth M, Cuglievan B, McCall D. Novel immunotherapeutic approaches for pediatric classical Hodgkin lymphoma: Nivolumab or brentuximab vedotin with the AVD regimen. Pediatr Blood Cancer. 2024 Aug; 71(8):e31091. PMID: 38840433.
      Citations:    Fields:    Translation:Humans
    8. Sarkar S, Rav E, Stitzlein L, Gibson A, McCall D, Nunez C, Roth M, Ragoonanan D, Connors J, Herzog CE, Cuglievan B, Garcia MB. Palbociclib and chemotherapy followed by blinatumomab consolidation to CAR-T cell therapy in KMT2A-rearranged, therapy-related acute lymphoblastic leukemia. Pediatr Blood Cancer. 2024 Jun; 71(6):e30964. PMID: 38514796.
      Citations:    Fields:    Translation:Humans
    9. He J, Munir F, Catueno S, Connors JS, Gibson A, Robusto L, McCall D, Nunez C, Roth M, Tewari P, Garces S, Cuglievan B, Garcia MB. Biological Markers of High-Risk Childhood Acute Lymphoblastic Leukemia. Cancers (Basel). 2024 Feb 21; 16(5). PMID: 38473221; PMCID: PMC10930495.
      Citations:    
    10. Sheikh IN, AlQahtani S, Yin CC, McCall D, Cuglievan B, Ragoonanan D, Connors JS, Gibson A, Nunez C, Roth M, Ohanian M, Borthakur G, Garcia MB. KIT-mutated pediatric core-binding factor systemic mastocytosis-acute myeloid leukemia treated with avapritinib and decitabine. Pediatr Blood Cancer. 2024 Apr; 71(4):e30898. PMID: 38291730.
      Citations:    Fields:    Translation:Humans
    11. Rodriguez M, Fekry B, Murphy B, Figueroa M, Cheng T, Raber M, Wartenberg L, Bell D, Triche L, Crawford K, Ma H, Allton K, Ahmed R, Tran J, Ranieri C, Konopleva M, Barton M, Nunez C, Eckel-Mahan K, Chandra J. Feasible diet and circadian interventions reduce in?vivo progression of FLT3-ITD-positive acute myeloid leukemia. Cancer Med. 2024 Jan; 13(2):e6949. PMID: 38334474; PMCID: PMC10854450.
      Citations:    Fields:    Translation:HumansAnimals
    12. Cuglievan B, Connors J, He J, Khazal S, Yedururi S, Dai J, Garces S, Quesada AE, Roth M, Garcia M, McCall D, Gibson A, Ragoonanan D, Petropoulos D, Tewari P, Nunez C, Mahadeo KM, Tasian SK, Lamble AJ, Pawlowska A, Hammond D, Maiti A, Haddad FG, Senapati J, Daver N, Gangat N, Konopleva M, Meshinchi S, Pemmaraju N. Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies. Leukemia. 2023 09; 37(9):1767-1778. PMID: 37452102; PMCID: PMC10457206.
      Citations: 2     Fields:    Translation:HumansCells
    13. Munir F, He J, Connors J, Garcia M, Gibson A, McCall D, Nunez C, Dinh CN, Robusto L, Roth M, Khazal S, Tewari P, Cuglievan B. Translational advances in the treatment of childhood acute lymphoblastic leukemia: narrative review of current and emerging molecular and immunotherapies. Transl Pediatr. 2023 Mar 31; 12(3):487-502. PMID: 37035397; PMCID: PMC10080491.
      Citations: 1     
    14. Rav ES, Wahba A, Patnaik A, Toruner G, Hittle A, Toepfer L, Roth M, Cuglievan B, Nunez C, McCall D. A balancing act: Blinatumomab use in a rare occurrence of Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia in an adolescent patient with Down syndrome. Pediatr Blood Cancer. 2023 05; 70(5):e30191. PMID: 36602024.
      Citations:    Fields:    Translation:HumansCells
    15. Ragoonanan D, Bhar S, Mohan G, Beltramo F, Khazal SJ, Hurley C, Andersen C, Margossian S, Neelapu SS, Shpall E, Gutierrez C, Tewari P, Shoberu B, Talleur A, McCall D, Nunez C, Cuglievan B, Tambaro FP, Petropoulos D, Abdel-Azim H, Mahadeo KM. A multicenter study of ICU resource utilization in pediatric, adolescent and young adult patients post CAR-T therapy. Front Oncol. 2022; 12:1022901. PMID: 36353531; PMCID: PMC9638171.
      Citations: 1     
    16. McCall D, Jabbour E, Roth M, Nunez C, Cuglievan B. Mini-hyper CVD + CRIB (condensed rituximab, inotuzumab ozogamicin, and blinatumomab) for refractory pediatric B-acute lymphoblastic leukemia. Pediatr Blood Cancer. 2023 01; 70(1):e29939. PMID: 36031729.
      Citations:    
    17. Qiu L, Nunez CA, Tang G, Cuglievan B, Issa GC, Wang SA, Medeiros LJ, Thakral B. A rare case of acute megakaryoblastic leukemia with t(11;17)(q23;q21) and KMT2A::MLLT6 fusion. Ann Hematol. 2022 07; 101(7):1579-1581. PMID: 35091795.
      Citations:    Fields:    Translation:Humans
    18. Gibson A, Trabal A, McCall D, Khazal S, Toepfer L, Bell DH, Roth M, Mahadeo KM, Nunez C, Short NJ, DiNardo C, Konopleva M, Issa GC, Ravandi F, Jain N, Borthakur G, Kantarjian HM, Jabbour E, Cuglievan B. Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma. Cancers (Basel). 2021 Dec 29; 14(1). PMID: 35008312; PMCID: PMC8750927.
      Citations: 2     
    19. McCall D, Roth M, Mahadeo KM, Toepfer L, Nunez C, Short NJ, Daver N, Kadia TM, DiNardo C, Yi JS, Cuglievan B. Gilteritinib combination therapies in pediatric patients with FLT3-mutated acute myeloid leukemia. Blood Adv. 2021 12 14; 5(23):5215-5219. PMID: 34592761; PMCID: PMC9153013.
      Citations: 1     Fields:    Translation:Humans
    20. Sheikh I, Nunez C, McCall D, Roth M, Cuglievan B. Programmed cell death protein blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation in an adolescent patient. Pediatr Blood Cancer. 2022 03; 69(3):e29390. PMID: 35077016.
      Citations:    Fields:    Translation:Humans
    21. Baig MU, Rytting M, Roth M, Morani AC, Nunez C, Lin P, Cuglievan B. Venetoclax and Decitabine in Pediatric Refractory T-cell Lymphoblastic Lymphoma. J Pediatr Hematol Oncol. 2021 Oct 01; 43(7):e991-e996. PMID: 33480649.
      Citations: 1     Fields:    Translation:Humans
    22. Samra B, Kantarjian HM, Sasaki K, Alotaibi AS, Konopleva M, O'Brien S, Ferrajoli A, Garris R, Nunez CA, Kadia TM, Short NJ, Jabbour E. Discontinuation of Maintenance Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia outside of Transplant. Acta Haematol. 2021; 144(3):285-292. PMID: 33238261.
      Citations:    Fields:    Translation:HumansCells
    23. Kohorst MA, Nunez CA, Tewari P, Petropoulos D, Mahadeo KM, Neelapu SS, Shpall EJ, Khazal S. Primary mediastinal large B-cell lymphoma in paediatric and adolescent patients: emerging questions in the era of immunotherapy. Br J Haematol. 2020 07; 190(2):e114-e117. PMID: 32469086.
      Citations: 2     Fields:    Translation:Humans
    24. Tambaro FP, Khazal S, Nunez C, Ragoonanan D, Tewari P, Petropoulos D, Kebriaei P, Wierda WG, Mahadeo KM. Complete remission in refractory acute lymphoblastic leukemia using blinatumomab after failure of response to CD-19 chimeric antigen receptor T-cell therapy. Clin Case Rep. 2020 Sep; 8(9):1678-1681. PMID: 32983475; PMCID: PMC7495807.
      Citations: 2     
    25. Kim EJ, Aria AB, Wilmas K, Lewis DJ, Torres-Cabala CA, Nunez C, Dabaja BS, Duvic M. Primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoproliferative disorder in a pediatric patient successfully treated with low-dose radiation. Pediatr Dermatol. 2019 Jan; 36(1):e23-e26. PMID: 30548331.
      Citations:    Fields:    Translation:HumansCells
    26. Jain N, Lu X, Daver N, Thakral B, Wang SA, Konoplev S, Patel K, Kanagal-Shamanna R, Valentine M, Tang G, Pemmaraju N, Jorgensen J, Kebriaei P, Nunez CA, Wierda W, Jabbour E, Roberts KG, Mullighan CG, Kantarjian H, Konopleva M. Co-occurrence of CRLF2-rearranged and Ph+ acute lymphoblastic leukemia: a report of four patients. Haematologica. 2017 12; 102(12):e514-e517. PMID: 28860345; PMCID: PMC5709127.
      Citations: 5     Fields:    Translation:HumansCells
    27. Lewis DJ, Turkeltaub AE, Dai J, Nagarajan P, Rieger KE, Nunez CA, Kim YH, Duvic M. An adolescent with granulomatous mycosis fungoides infiltrating skeletal muscle successfully treated with oral prednisone. JAAD Case Rep. 2017 Jul; 3(4):276-279. PMID: 28653029; PMCID: PMC5475354.
      Citations:    
    28. Kontoyiannis DP, DePombo AM, Bhatti MM, Tverdek FP, Gettys SC, Nicolau DP, Nunez CA, Aitken SL. Use of Ceftolozane/Tazobactam in the Treatment of Multidrug-resistant Pseudomonas aeruginosa Bloodstream Infection in a Pediatric Leukemia Patient. Pediatr Infect Dis J. 2016 09; 35(9):1040-2. PMID: 27254038.
      Citations: 16     Fields:    Translation:HumansCells
    29. Wieser I, Wohlmuth C, Nunez CA, Duvic M. Lymphomatoid Papulosis in Children and Adolescents: A Systematic Review. Am J Clin Dermatol. 2016 Aug; 17(4):319-27. PMID: 27138554.
      Citations: 3     Fields:    Translation:Humans
    30. Ghantoji SS, Shah DP, Shah JN, El Taoum KK, Champlin RE, Nunez CA, Mulanovich V, Ariza-Heredia E, Chemaly RF. Respiratory syncytial virus infections in children with cancer. J Pediatr Hematol Oncol. 2014 Aug; 36(6):e376-81. PMID: 24327130.
      Citations: 10     Fields:    Translation:Humans
    31. Corrales-Medina FF, Herzog C, Hess K, Egas-Bejar D, Hong DS, Falchook G, Anderson P, Nunez C, Huh WW, Naing A, Tsimberidou AM, Wheler J, Paul SP, Janku F, Kleinerman ES, Kurzrock R, Subbiah V. Clinical characteristics and outcomes of pediatric oncology patients with aggressive biology enrolled in phase I clinical trials designed for adults: the university of Texas MD anderson cancer center experience. Oncoscience. 2014 Jul 27; 1(7):522-530. PMID: 25587555; PMCID: PMC4278323.
      Citations: 2     
    32. Fanale M, Fayad L, Pro B, Samaniego F, Liboon MJ, Nunez C, Horowitz S, Anderlini P, Popat U, Ji Y, Kwak LW, Younes A. Phase I study of bortezomib plus ICE (BICE) for the treatment of relapsed/refractory Hodgkin lymphoma. Br J Haematol. 2011 Jul; 154(2):284-6. PMID: 21517809.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    33. Hudson MM, Rai SN, Nunez C, Merchant TE, Marina NM, Zalamea N, Cox C, Phipps S, Pompeu R, Rosenthal D. Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors. J Clin Oncol. 2007 Aug 20; 25(24):3635-43. PMID: 17704413.
      Citations: 40     Fields:    Translation:Humans
    34. Hijiya N, Metzger ML, Pounds S, Schmidt JE, Razzouk BI, Rubnitz JE, Howard SC, Nunez CA, Pui CH, Ribeiro RC. Severe cardiopulmonary complications consistent with systemic inflammatory response syndrome caused by leukemia cell lysis in childhood acute myelomonocytic or monocytic leukemia. Pediatr Blood Cancer. 2005 Jan; 44(1):63-9. PMID: 15368547.
      Citations: 14     Fields:    Translation:Humans
    35. Zipf TF, Roberts WM, Medeiros LJ, Hayes K, Bueso-Ramos CE, Nu?ez CA. Molecular monitoring of cerebrospinal fluid can predict clinical relapse in acute lymphoblastic leukemia with eosinophilia. Arch Pathol Lab Med. 2003 May; 127(5):601-5. PMID: 12708906.
      Citations: 5     Fields:    Translation:Humans
    36. Bueso-Ramos C, Medeiros LJ, Zipf T, Nunez C, Tubergen D. Tenupodia formation by blasts in bone marrow aspirate smears from a patient with acute monoblastic leukemia. Blood. 1999 Dec 01; 94(11):3954-5. PMID: 10627120.
      Citations:    Fields:    Translation:HumansCells
    37. Shiokawa S, Mortari F, Lima JO, Bertrand FE, Kirkham PM, Zhu S, Dasanayake AP, Schroeder HW, Nu?ez C. IgM heavy chain complementarity-determining region 3 diversity is constrained by genetic and somatic mechanisms until two months after birth. J Immunol. 1999 May 15; 162(10):6060-70. PMID: 10229847.
      Citations: 47     Fields:    Translation:HumansAnimalsCells
    38. Chan KW, Békássy AN, Ha CS, Nunez C, Alvegård TA, Sallerfors B, B?k?ssy AN, Alveg?rd TA. Fludarabine-based preparative protocol for unrelated donor cord blood transplantation in children: successful engraftment with minimal toxicity. Bone Marrow Transplant. 1999 Apr; 23(8):849-51. PMID: 10231153.
      Citations:    Fields:    Translation:Humans
    39. Nunez R, Sanchez M, Wild P, Filgueira L, Nunez C. Characterisation of two human dendritic cell-lines that express CD1a, take-up, process and present soluble antigens and induce MLR. Immunol Lett. 1998 Mar; 61(1):33-43. PMID: 9562373.
      Citations: 1     Fields:    Translation:HumansCells
    40. Nishimoto N, Gartland GL, Billips LG, Burrows PD, Kubagawa H, Cooper MD, Nu?ez C. B cells are generated throughout life in humans. J Immunol. 1996 Jan 15; 156(2):866-72. PMID: 8543844.
      Citations: 46     Fields:    Translation:HumansCells
    41. Billips LG, Bertrand FE, Stankovic AK, Gartland GL, Burrows PD, Cooper MD, Nu?ez CA. Immunoglobulin recombinase gene activity is modulated reciprocally by interleukin 7 and CD19 in B cell progenitors. J Exp Med. 1995 Oct 01; 182(4):973-82. PMID: 7561700; PMCID: PMC2192306.
      Citations: 20     Fields:    Translation:HumansCells
    42. Billips LG, Lassoued K, Wang J, Kubagawa H, Gartland GL, Burrows PD, Cooper MD, Nu?ez C. Human B-cell development. Ann N Y Acad Sci. 1995 Sep 29; 764:1-8. PMID: 7486507.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    43. Lassoued K, Billips L, Kubagawa H, Monteiro RC, LeBlen TW, Cooper MD, Nu?ez CA. Expression of surrogate light chain receptors is restricted to a late stage in pre-B cell differentiation. Cell. 1993 Apr 09; 73(1):73-86. PMID: 7681728.
      Citations: 26     Fields:    Translation:HumansAnimalsCells
    44. Nunez R, Munoz A, Nunez C, Gomez B. A micro ELISA for the diagnosis of cerebral cisticercosis. J Immunoassay. 1989; 10(2-3):169-76. PMID: 2745716.
      Citations:    Fields:    Translation:Humans
    45. Cramer SF, Roth LM, Ulbright TM, Mazur MT, Nunez CA, Gersell DJ, Mills SE, Kraus FT. Evaluation of the reproducibility of the World Health Organization classification of common ovarian cancers. With emphasis on methodology. Arch Pathol Lab Med. 1987 Sep; 111(9):819-29. PMID: 3632299.
      Citations: 6     Fields:    Translation:Humans
    46. Raad J, N??ez RM, N??ez CA. Antibodies against spermatozoids. Studies in homosexuals, AIDS and infertile men. Allergol Immunopathol (Madr). 1987 Jul-Aug; 15(4):215-9. PMID: 3318351.
      Citations:    Fields:    Translation:HumansCells
    47. Use of ceftolozane/tazobactam in the treatment of multidrug-resistant pseudomonas aeruginosa bloodstream infection in a pediatric leukemia patient. Pediatric Infectious Disease Journal. 35:1040-1042.
    48. Lymphomatoid Papulosis in Children and Adolescents. American Journal of Clinical Dermatology. 17:319-327.
    49. Clinical characteristics and outcomes of pediatric oncology patients with aggressive biology enrolled in phase I clinical trials designed for adults. Oncoscience. 1:522-530.
    50. The expression of long HCDR3 intervals is constrained by both genetic and somatic mechanisms during human B-cell ontogeny. Journal of Investigative Medicine. 47.
    NUNEZ's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (239)
    Explore
    _
    Co-Authors (58)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _